Human data and translational research is a high priority for ELIXIR and builds on the progress made in the previous programmes by the Human Data Communities. Within the Science Tier of the ELIXIR 2024–2028 Programme, advances will be focussed on enabling researchers (including research clinicians) to use ELIXIR’s infrastructure, for human genomic, phenotypic, imaging and demographic data to support discovery, analysis, innovation and integration of research findings into the clinic and healthcare.

Cellular and molecular biology are fundamental to ELIXIR's mission. As part of our 2024–28 Programme, we are committed to advancing data services and software for research on nucleic acids, proteins and other biomolecules. This initiative will address new demands for multi-omics and multi-modal analyses, including imaging, by developing methods and partnerships. We will also expand expertise in reusable data and software to incorporate FAIR models, ensuring robust solutions for modelling at all scales. 

Over the coming decade, Europe will face critical challenges in maintaining biodiversity, ensuring food security and combating pathogens. Our 2024–28 Programme will address these issues by mobilising and integrating molecular data, using successful coordination models from human genomics. Through strategic investments and collaboration in externally-funded projects, ELIXIR will enhance scientific services and support transnational research in these essential areas.